CVM Logo

CEL-SCI Corporation (CVM) 

AMEX
Market Cap
$62.83M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
284 of 809
Rank in Industry
166 of 445

Largest Insider Buys in Sector

CVM Stock Price History Chart

CVM Stock Performance

About CEL-SCI Corporation

CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, and parasitic infections, as well as autoimmune diseases, allergies, transplantation rejections, and cancer. The company also develops LEAPS-H1N1-DC; CEL-2000 and CEL-4000 are product candidates for the treatment of rheumatoid arthritis; and LEAPS COV-19, a product candidate to treat COVID-19 coronavirus. CEL-SCI Corporation has a collaboration agreement with the University of Georgia's Center for Vaccines and Immunology to develop LEAPS COVID-19 immunotherapy. The company was incorporated in 1983 and is headquartered in Vienna, Virginia.

Insider Activity of CEL-SCI Corporation

Over the last 12 months, insiders at CEL-SCI Corporation have bought $80,620 and sold $0 worth of CEL-SCI Corporation stock.

On average, over the past 5 years, insiders at CEL-SCI Corporation have bought $159,307 and sold $245,053 worth of stock each year.

Highest buying activity among insiders over the last 12 months: Watson Robert Eugene (director) — $55,600. KERSTEN GEERT R (Chief Executive Officer) — $41,700. PRICHEP PATRICIA B (Senior Vice President) — $11,120.

The last purchase of 30,000 shares for transaction amount of $41,700 was made by KERSTEN GEERT R (Chief Executive Officer) on 2024‑05‑08.

List of Insider Buy and Sell Transactions, CEL-SCI Corporation

2024-05-08PurchaseKERSTEN GEERT RChief Executive Officer
30,000
0.0556%
$1.39$41,700-7.91%
2024-05-08PurchasePRICHEP PATRICIA BSenior Vice President
8,000
0.0148%
$1.39$11,120-7.91%
2024-05-08PurchaseWatson Robert Eugenedirector
20,000
0.0371%
$1.39$27,800-7.91%
2021-10-19SaleTALOR EYALChief Scientific Officer
15,000
0.0345%
$11.25$168,750-63.02%
2021-07-06PurchaseKERSTEN GEERT RChief Executive Officer
25,000
0.0615%
$8.00$200,000-9.69%
2021-07-06PurchaseBAILLAVOINE BRUNO JEAN-MARIEdirector
1,250
0.0031%
$8.00$10,000-9.69%
2021-07-06PurchaseWatson Robert Eugenedirector
1,250
0.0031%
$8.00$10,000-9.69%
2021-06-28PurchaseYOUNG PETER Rdirector
3,000
0.0068%
$12.66$37,971-44.12%
2021-04-22SaleCIPRIANO JOHNSenior Vice President
10,000
0.0244%
$24.38$243,793-62.09%
2020-12-11PurchaseYOUNG PETER Rdirector
100
0.0003%
$14.24$1,424-8.02%
2020-11-18PurchaseBAILLAVOINE BRUNO JEAN-MARIEdirector
800
0.0021%
$11.77$9,416+16.45%
2020-11-18PurchaseWatson Robert Eugenedirector
800
0.0021%
$11.77$9,416+16.45%
2020-11-17PurchaseYOUNG PETER Rdirector
800
0.0021%
$11.68$9,343+16.15%
2020-11-13SaleCIPRIANO JOHNSenior Vice President
10,000
0.026%
$12.73$127,290+6.47%
2020-11-04PurchaseYOUNG PETER Rdirector
3,000
0.0076%
$11.35$34,060+16.45%
2020-02-26PurchaseKERSTEN GEERT RChief Executive Officer
4,617
0.0128%
$10.83$50,002+23.45%
2020-02-26PurchasePRICHEP PATRICIA BSenior Vice President
3,694
0.0051%
$5.42$20,003+23.45%
2020-02-26PurchaseZIMMERMAN DANIEL HSenior Vice President
923
0.0026%
$10.83$9,996+23.45%
2020-02-26PurchaseYOUNG PETER Rdirector
923
0.0026%
$10.83$9,996+23.45%
2020-02-26PurchaseBAILLAVOINE BRUNO JEAN-MARIEdirector
923
0.0026%
$10.83$9,996+23.45%

Insider Historical Profitability

15.03%
KERSTEN GEERT RChief Executive Officer
1195309
2.2935%
$1.16300+9.11%
PRICHEP PATRICIA BSenior Vice President
232326
0.4107%
$1.1670+0.31%
Watson Robert Eugenedirector
24431
0.0089%
$1.1640+10.07%
KINSOLVING C RICHARDdirector
302247
0.6047%
$1.1604
DE CLARA MAXIMILIANPresident
251234
0.5027%
$1.16067
ZIMMERMAN DANIEL HSenior Vice President
114387
0.2289%
$1.1653+23.45%
TALOR EYALChief Scientific Officer
104899
0.2099%
$1.16416
CIPRIANO JOHNSenior Vice President
63108
0.1263%
$1.1635
YOUNG PETER Rdirector
28914
0.0579%
$1.16132+23.96%
BAILLAVOINE BRUNO JEAN-MARIEdirector
5973
0.012%
$1.1630+10.07%
ESTERHAZY ALEXANDER Gdirector
0
0%
$1.1608

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
The Vanguard Group$4.19M4.052.19M+5.47%+$217,172.75<0.0001
Cvi Holdings Llc$1.68M1.62878,767New+$1.68M1.73
BlackRock$1.46M1.41763,443+1.14%+$16,498.58<0.0001
Susquehanna International Group$1.28M1.24668,989+72.28%+$536,091.16<0.01
Geode Capital Management$887,256.000.86464,409-2.92%-$26,726.06<0.0001
Advisor Group Holdings Inc$588,616.000.57308,178-15.45%-$107,562.83<0.01
State Street$370,553.000.36194,0070%+$0<0.0001
D. E. Shaw & Co.$360,121.000.35188,545+78.59%+$158,474.63<0.0001
Two Sigma$304,645.000.29159,500+58.63%+$112,602.14<0.01
Bridgeway Capital Management$290,129.000.28151,900+1.33%+$3,820.000.01
Renaissance Technologies$256,000.000.25133,800+237.03%+$180,041.85<0.0001
Northern Trust$226,110.000.22118,382+41.16%+$65,929.49<0.0001
Lincoln National Corporation$220,118.000.21115,245+32.4%+$53,862.01<0.01
Cutter Co Brokerage Inc$160,079.000.1683,811-1.06%-$1,719.000.03
Millennium Management LLC$133,085.000.1369,678New+$133,085.00<0.0001
Jane Street Capital$112,458.000.1158,879-2.24%-$2,574.66<0.0001
Thoroughbred Financial Inc$108,000.000.1156,760-55.22%-$133,194.290.01
Black Diamond Financial, LLC$144,160.000.153,0000%+$00.04
UBS$99,929.000.152,319+134.48%+$57,311.29<0.0001
Cantor Fitzgerald L P$91,683.000.0950,100-58.59%-$129,747.00<0.01
Group One Trading$78,203.000.0840,944-42.09%-$56,841.57<0.01
Citadel Advisors LLC$67,889.000.0735,544-23.59%-$20,956.51<0.0001
D.A. Davidson Companies$61,693.000.0632,300-88.9%-$493,979.48<0.01
Simplex Trading Llc$59,000.000.0631,364+10.08%+$5,404.51<0.01
Bank of America$55,686.000.0529,155-4.63%-$2,704.56<0.0001
Creative Planning$50,615.000.0526,5000%+$0<0.0001
T. Rowe Price$52,000.000.0526,8000%+$0<0.0001
Gsa Capital Partners Llp$49,000.000.0525,561New+$49,000.00<0.01
Vontobel Holding Ltd$47,750.000.0525,0000%+$0<0.0001
LINSCO PRIVATE LEDGER CORP$43,565.000.0422,8090%+$0<0.0001
Sheets Smith Wealth Management, Inc.$38,200.000.0420,0000%+$0<0.01
Stifel$38,200.000.0420,000New+$38,200.00<0.0001
Man Group Plc$37,602.000.0419,687-54.13%-$44,371.01<0.0001
Raymond James Associates$36,057.000.0418,8780%+$0<0.0001
Wells Fargo$35,622.000.0318,650+6.01%+$2,020.81<0.0001
Morgan Stanley$34,608.000.0318,119-58.25%-$48,283.88<0.0001
Virtu Financial Llc$34,000.000.0317,781-70.41%-$80,914.68<0.01
Citigroup$32,663.000.0317,101-88.7%-$256,380.01<0.0001
Chilton Capital Management LLC$31,137.000.0316,302+297.42%+$23,302.13<0.01
Charles Schwab$31,479.000.0316,4810%+$0<0.0001
Dimensional Fund Advisors$31,484.000.0316,484-33.34%-$15,749.64<0.0001
Xtx Topco Ltd$31,173.000.0316,321New+$31,173.00<0.01
Ameriprise Financial$29,643.000.0315,5200%+$0<0.0001
Nations Financial Group Inc Ia Adv$28,650.000.0315,0000%+$0<0.01
Benedetti Gucer Inc$27,000.000.0314,320-14.35%-$4,525.140.02
Toroso Investments Llc$26,532.000.0313,891New+$26,532.00<0.0001
Cresset Asset Management Llc$23,638.000.0212,3760%+$0<0.0001
TWO SIGMA SECURITIES LLC$22,099.000.0211,570New+$22,099.00<0.0001
Squarepoint Ops LLC$21,612.000.0211,315New+$21,612.00<0.0001
Qube Research & Technologies$21,134.000.0211,065+8.09%+$1,581.47<0.0001